DK1047409T3 - TTS indeholdende en antioxidant - Google Patents

TTS indeholdende en antioxidant

Info

Publication number: DK1047409T3
Authority: DK; Denmark
Prior art keywords: antioxidant; ethyl; tts containing; tts; carbamate
Prior art date: 1998-01-12

Application number

DK99902525T

Other languages

Danish (da)

English (en)

Inventor

Bodo Asmussen

Michael Horstmann

Kai Koepke

Harry Tiemessen

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-12

Filing date

1999-01-08

Publication date

2002-12-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1047409(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-01-08 Application filed by Novartis Ag filed Critical Novartis Ag

2002-12-30 Application granted granted Critical

2002-12-30 Publication of DK1047409T3 publication Critical patent/DK1047409T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Anti-Oxidant Or Stabilizer Compositions (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Fats And Perfumes (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Dental Preparations (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Compositions Of Macromolecular Compounds (AREA)

DK99902525T 1998-01-12 1999-01-08 TTS indeholdende en antioxidant DK1047409T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9800526.7A GB9800526D0 (en)	1998-01-12	1998-01-12	Organic compounds
PCT/EP1999/000078 WO1999034782A1 (fr)	1998-01-12	1999-01-08	Systeme transdermique contenant un antioxydant

Publications (1)

Publication Number	Publication Date
DK1047409T3 true DK1047409T3 (da)	2002-12-30

Family

ID=10825116

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99902525T DK1047409T3 (da)	1998-01-12	1999-01-08	TTS indeholdende en antioxidant

Country Status (25)

Country	Link
US (1)	US6335031B1 (fr)
EP (1)	EP1047409B1 (fr)
KR (1)	KR100569051B1 (fr)
CN (1)	CN1129427C (fr)
AT (1)	ATE223711T1 (fr)
AU (1)	AU745661B2 (fr)
BR (1)	BR9906920A (fr)
CA (1)	CA2315784C (fr)
CZ (1)	CZ300598B6 (fr)
DE (1)	DE69902875T2 (fr)
DK (1)	DK1047409T3 (fr)
ES (1)	ES2184408T3 (fr)
GB (1)	GB9800526D0 (fr)
HU (1)	HU227159B1 (fr)
ID (1)	ID27503A (fr)
IL (1)	IL137100A (fr)
MX (1)	MXPA00006438A (fr)
NO (1)	NO328390B1 (fr)
NZ (1)	NZ505650A (fr)
PL (1)	PL201328B1 (fr)
PT (1)	PT1047409E (fr)
RU (1)	RU2219926C2 (fr)
SK (1)	SK284622B6 (fr)
TR (2)	TR200101021T2 (fr)
WO (1)	WO1999034782A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU764866B2 (en) *	1998-10-01	2003-09-04	Novartis Ag	New sustained release oral formulations
FR2793689B1 (fr) *	1999-05-19	2001-08-24	Pf Medicament	Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
EP1233763B1 (fr) *	1999-11-29	2003-07-30	LTS Lohmann Therapie-Systeme AG	Systemes therapeutiques transdermiques ayant une stabilite amelioree et procede de fabrication
DE10107663B4 (de) *	2001-02-19	2004-09-09	Lts Lohmann Therapie-Systeme Ag	Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) *	2002-04-15	2003-10-15	F T Holding S A	Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) *	2005-02-04	2006-08-11	Frederic Khodja	Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh)	2005-12-01	2013-03-21	Novartis Ag	經皮治療系統
WO2009022345A1 (fr) *	2007-08-14	2009-02-19	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Carbamates de phényle destinés au traitement de la sclérose en plaques
UY32008A (es) *	2008-07-28	2010-02-26	Takeda Pharmaceutical	Composición farmacéutica
US20100087768A1 (en) *	2008-10-02	2010-04-08	Forlano Paula	Transdermal drug delivery system for liquid active ingredient
MX350357B (es)	2009-12-22	2017-09-05	Luye Pharma Ag	Sistema terapeutico transdermico para administrar rivastigmina o derivados de este.
US10076502B2 (en)	2009-12-22	2018-09-18	Luye Pharma Ag	Transdermal therapeutic system for administering rivastigmine or derivatives thereof
ES2363395B1 (es) *	2010-01-20	2012-02-23	Farmalider, S.A.	Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (fr)	2010-06-02	2011-12-08	Noscira, S.A.	Traitement combiné comprenant un inhibiteur de la cholinestérase et un dérivé de thiadiazolidinedione
DE102010026903A1 (de)	2010-07-12	2012-01-12	Amw Gmbh	Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
EP2596071B1 (fr)	2010-07-21	2019-02-13	3M Innovative Properties Company	Compositions adhésives transdermiques, dispositifs et procédés
ES2545094T3 (es)	2010-12-14	2015-09-08	Acino Ag	Sistema terapéutico transdérmico para la administración de un principio activo
KR101788802B1 (ko) *	2010-12-24	2017-10-20	주식회사 삼양바이오팜	리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) *	2011-05-13	2012-11-21	에스케이케미칼주식회사	리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
BR112013029945A2 (pt)	2011-05-20	2017-01-31	Sk Chemicals Co Ltd	emplastro contendo rivastigmina
KR20120130073A (ko) *	2011-05-20	2012-11-28	에스케이케미칼주식회사	리바스티그민 함유 패취
EP2594261A1 (fr)	2011-11-18	2013-05-22	Labtec GmbH	Composition pour administration transdermique de rivastigmine
DE102012000369A1 (de)	2012-01-11	2013-07-11	Alfred E. Tiefenbacher (Gmbh & Co. Kg)	Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (fr)	2012-03-23	2013-09-26	Novartis Ag	Système thérapeutique transdermique et procédé associé
PL2859892T3 (pl)	2012-06-12	2023-10-16	KM Transderm Ltd.	Plaster
WO2014034939A1 (fr) *	2012-09-03	2014-03-06	ニプロパッチ株式会社	Patch cutané adhésif
KR20140038237A (ko)	2012-09-20	2014-03-28	에스케이케미칼주식회사	리바스티그민의 안정성이 개선된 의약품
WO2014051128A1 (fr)	2012-09-28	2014-04-03	株式会社ケイ・エムトランスダーム	Timbre transdermique
WO2014111790A2 (fr)	2013-01-15	2014-07-24	Zydus Technologies Limited	Système d'administration de médicament pharmaceutique transdermique stable comprenant de la rivastigmine
US9949935B2 (en) *	2014-04-08	2018-04-24	Teikoku Pharma Usa, Inc.	Rivastigmine transdermal compositions and methods of using the same
JPWO2015174502A1 (ja)	2014-05-15	2017-05-25	ニチバン株式会社	リバスチグミンを含有する貼付剤のための包装体
KR102710072B1 (ko)	2018-08-31	2024-09-24	에스케이케미칼 주식회사	장기 투여용 리바스티그민 패취
KR102823139B1 (ko)	2018-08-31	2025-06-19	에스케이케미칼 주식회사	장기 투여용 리바스티그민 패취
EP4108243A4 (fr) *	2020-02-19	2024-04-17	Sumitomo Pharma Co., Ltd.	Préparation à absorption transdermique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU201906B (en) *	1987-03-04	1991-01-28	Sandoz Ag	Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
GB9213322D0 (en) *	1992-06-23	1992-08-05	Efamol Holdings	Antioxidant compositions
AU5716898A (en) *	1997-01-08	1998-08-03	Warner-Lambert Company	Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
EP0952826B1 (fr) *	1997-01-17	2001-11-14	Takeda Chemical Industries, Ltd.	Agent combine contenant de l'idebenone pour le traitement de la maladie d'alzheimer

1998
- 1998-01-12 GB GBGB9800526.7A patent/GB9800526D0/en not_active Ceased
1999
- 1999-01-08 EP EP99902525A patent/EP1047409B1/fr not_active Expired - Lifetime
- 1999-01-08 BR BR9906920-2A patent/BR9906920A/pt not_active Application Discontinuation
- 1999-01-08 TR TR2001/01021T patent/TR200101021T2/xx unknown
- 1999-01-08 CN CN99802092A patent/CN1129427C/zh not_active Expired - Lifetime
- 1999-01-08 NZ NZ505650A patent/NZ505650A/xx not_active IP Right Cessation
- 1999-01-08 WO PCT/EP1999/000078 patent/WO1999034782A1/fr not_active Ceased
- 1999-01-08 AU AU22785/99A patent/AU745661B2/en not_active Expired
- 1999-01-08 PL PL341347A patent/PL201328B1/pl unknown
- 1999-01-08 CA CA002315784A patent/CA2315784C/fr not_active Expired - Lifetime
- 1999-01-08 ES ES99902525T patent/ES2184408T3/es not_active Expired - Lifetime
- 1999-01-08 MX MXPA00006438A patent/MXPA00006438A/es active IP Right Grant
- 1999-01-08 TR TR2000/01688T patent/TR200001688T2/xx unknown
- 1999-01-08 IL IL13710099A patent/IL137100A/en not_active IP Right Cessation
- 1999-01-08 DK DK99902525T patent/DK1047409T3/da active
- 1999-01-08 PT PT99902525T patent/PT1047409E/pt unknown
- 1999-01-08 KR KR1020007006433A patent/KR100569051B1/ko not_active Ceased
- 1999-01-08 ID IDW20001301A patent/ID27503A/id unknown
- 1999-01-08 DE DE69902875T patent/DE69902875T2/de not_active Expired - Lifetime
- 1999-01-08 SK SK1053-2000A patent/SK284622B6/sk not_active IP Right Cessation
- 1999-01-08 AT AT99902525T patent/ATE223711T1/de active
- 1999-01-08 CZ CZ20002557A patent/CZ300598B6/cs not_active IP Right Cessation
- 1999-01-08 HU HU0004300A patent/HU227159B1/hu unknown
- 1999-01-08 RU RU2000120951/15A patent/RU2219926C2/ru active
- 1999-04-14 US US09/291,498 patent/US6335031B1/en not_active Expired - Lifetime
2000
- 2000-07-05 NO NO20003472A patent/NO328390B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
GB9800526D0 (en)	1998-03-11
WO1999034782A1 (fr)	1999-07-15
ID27503A (id)	2001-04-12
US6335031B1 (en)	2002-01-01
TR200101021T2 (tr)	2002-06-21
PT1047409E (pt)	2002-12-31
MXPA00006438A (es)	2003-07-21
CA2315784C (fr)	2006-06-27
JP3820103B2 (ja)	2006-09-13
HUP0004300A2 (hu)	2001-05-28
EP1047409B1 (fr)	2002-09-11
NO328390B1 (no)	2010-02-08
IL137100A (en)	2004-12-15
ATE223711T1 (de)	2002-09-15
KR100569051B1 (ko)	2006-04-10
HUP0004300A3 (en)	2003-05-28
DE69902875D1 (de)	2002-10-17
HU227159B1 (en)	2010-09-28
EP1047409A1 (fr)	2000-11-02
ES2184408T3 (es)	2003-04-01
JP2002500178A (ja)	2002-01-08
CA2315784A1 (fr)	1999-07-15
TR200001688T2 (tr)	2000-11-21
AU2278599A (en)	1999-07-26
DE69902875T2 (de)	2003-05-22
NO20003472L (no)	2000-08-07
KR20010033072A (ko)	2001-04-25
CN1129427C (zh)	2003-12-03
SK10532000A3 (sk)	2000-11-07
NZ505650A (en)	2002-10-25
AU745661B2 (en)	2002-03-28
PL201328B1 (pl)	2009-03-31
NO20003472D0 (no)	2000-07-05
RU2219926C2 (ru)	2003-12-27
CN1288375A (zh)	2001-03-21
CZ300598B6 (cs)	2009-06-24
PL341347A1 (en)	2001-04-09
SK284622B6 (sk)	2005-08-04
CZ20002557A3 (cs)	2000-10-11
BR9906920A (pt)	2000-10-10
HK1034036A1 (en)	2001-10-12
IL137100A0 (en)	2001-06-14

Publication	Publication Date	Title
DK1047409T3 (da)	2002-12-30	TTS indeholdende en antioxidant
BG66093B1 (bg)	2011-04-29	Състави с контролирано освобождаване, съдържащи нимесулид
BR0008590A (pt)	2001-10-30	Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
AR037081A1 (es)	2004-10-20	Composicion para el suministro transdermico de fentanilo
BR0107869A (pt)	2002-11-05	Composições farmacêuticas eletrogiradas
TR200502189T1 (tr)	2007-01-22	Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler.
ATE288256T1 (de)	2005-02-15	Dermale zusammensetzungen
ATE383849T1 (de)	2008-02-15	Transdermale pharmazeutische zusammensetzung
TR199802108T2 (xx)	1999-01-18	�bandronat i�eren oral farmas�tik bir form�lasyon.
BR9405798A (pt)	1995-12-12	Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
DE69531741D1 (de)	2003-10-16	Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
SE9301171D0 (sv)	1993-04-07	Pharmaceutical composition containing lipophilic drugs
EP1708686A4 (fr)	2007-12-26	Forme galenique de fentanyl generalement lineaire effervescente et orale et ses procedes d'administration
BR0109150A (pt)	2003-04-22	Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
ATE324907T1 (de)	2006-06-15	Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
CY1108700T1 (el)	2014-04-09	Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης
ATE493973T1 (de)	2011-01-15	Irbesartan enthaltende pharmazeutische zusammensetzung
DE60019334D1 (de)	2005-05-12	Antivirale arznei
HUP0100539A2 (hu)	2001-08-28	D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
CO5640120A2 (es)	2006-05-31	Formulacion y metodods para el tratamiento de trombocitemia
TR200400241T4 (tr)	2004-04-21	Lasofoksifen'in transdermal olarak verilmesi
DK1300143T3 (da)	2007-07-09	Plaster som indeholder 4-biphenyleddikesyre
HRP20080178T3 (hr)	2008-05-31	Farmaceutski pripravak u obliku hidrogela za transdermalnu primjenu aktivnih tvari
BR0001144B1 (pt)	2013-10-22	Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase